Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Actavis plc | 25,081 | reported | 30 Apr 2019 | tx 12+27,409−2,051 |
| OptimizeRx Corp | 21,620 | reported | 11 Jun 2025 | tx 5+26,729−5,109 |
| PHARMACEUTICAL PRODUCT DEVELOPMENT INC | 16,199 | reported | 03 Jan 2011 | tx 49+93,178−48,000 |
| WATSON PHARMACEUTICALS INC | 0 | reported | 01 Oct 2013 | tx 23+66,342−73,009 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 11 Jun 2025 | GRANT_AWARD | OptimizeRx Corp | 9,868 | 0.00 USD | |
| 02 Feb 2025 | EXERCISE | OptimizeRx Corp | 5,109 | 0.00 USD | |
| 02 Feb 2025 | EXERCISE | OptimizeRx Corp | 5,109 | 0.00 USD | deriv |
| 07 Jun 2024 | GRANT_AWARD | OptimizeRx Corp | 6,643 | 0.00 USD | |
| 02 Feb 2024 | GRANT_AWARD | OptimizeRx Corp | 5,109 | 0.00 USD | deriv |
| 30 Apr 2019 | TAX_WITHHOLDING | Actavis plc | 953 | 147.00 USD | |
| 11 Mar 2019 | OTHER | Actavis plc | 410 | 0.00 USD | |
| 02 May 2018 | GRANT_AWARD | Actavis plc | 1,985 | 151.07 USD | |
| 04 May 2017 | GRANT_AWARD | Actavis plc | 1,223 | 245.25 USD | |
| 08 Aug 2016 | GRANT_AWARD | Actavis plc | 201 | 248.31 USD | |
| 05 May 2016 | GRANT_AWARD | Actavis plc | 1,188 | 210.34 USD | |
| 04 Jun 2015 | TAX_WITHHOLDING | Actavis plc | 549 | 303.38 USD | |
| 05 Jun 2015 | GRANT_AWARD | Actavis plc | 826 | 302.30 USD | |
| 09 May 2014 | GRANT_AWARD | Actavis plc | 1,142 | 197.05 USD | |
| 01 Oct 2013 | GRANT_AWARD | Actavis plc | 19,608 | — | |
| 01 Oct 2013 | OTHER | WATSON PHARMACEUTICALS INC | 19,608 | — | |
| 06 Aug 2013 | GIFT | WATSON PHARMACEUTICALS INC | 5,000 | 0.00 USD | |
| 12 Aug 2013 | SALE | WATSON PHARMACEUTICALS INC | 1,667 | 133.03 USD | |
| 09 Aug 2013 | GIFT | WATSON PHARMACEUTICALS INC | 3,334 | 0.00 USD | |
| 10 May 2013 | GRANT_AWARD | WATSON PHARMACEUTICALS INC | 1,877 | 0.00 USD | |
| 31 Jul 2012 | SALE | WATSON PHARMACEUTICALS INC | 5,000 | 78.38 USD | |
| 31 Jul 2012 | SALE | WATSON PHARMACEUTICALS INC | 5,000 | 78.38 USD | |
| 31 Jul 2012 | SALE | WATSON PHARMACEUTICALS INC | 11,700 | 78.38 USD | |
| 31 Jul 2012 | EXERCISE | WATSON PHARMACEUTICALS INC | 5,000 | 29.03 USD | |
| 31 Jul 2012 | EXERCISE | WATSON PHARMACEUTICALS INC | 11,700 | 44.14 USD |